202 related articles for article (PubMed ID: 22684543)
41. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo.
Xu XM; Yuan GJ; Deng JJ; Guo HT; Xiang M; Yang F; Ge W; Chen SY
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):193-202. PubMed ID: 22484589
[TBL] [Abstract][Full Text] [Related]
43. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
44. 12-o-Tetradecanoylphorbol 13-acetate prevents baicalein-induced apoptosis via activation of protein kinase C and JNKs in human leukemia cells.
Chow JM; Shen SC; Wu CY; Chen YC
Apoptosis; 2006 Nov; 11(11):1999-2011. PubMed ID: 17013757
[TBL] [Abstract][Full Text] [Related]
45. Baicalein Induces Caspase-dependent Apoptosis Associated with the Generation of ROS and the Activation of AMPK in Human Lung Carcinoma A549 Cells.
Kim HJ; Park C; Han MH; Hong SH; Kim GY; Hong SH; Kim ND; Choi YH
Drug Dev Res; 2016 Mar; 77(2):73-86. PubMed ID: 26971531
[TBL] [Abstract][Full Text] [Related]
46. Baicalein protects human melanocytes from H₂O₂-induced apoptosis via inhibiting mitochondria-dependent caspase activation and the p38 MAPK pathway.
Liu B; Jian Z; Li Q; Li K; Wang Z; Liu L; Tang L; Yi X; Wang H; Li C; Gao T
Free Radic Biol Med; 2012 Jul; 53(2):183-93. PubMed ID: 22569306
[TBL] [Abstract][Full Text] [Related]
47. Baicalein, a novel apoptotic agent for hepatoma cell lines: a potential medicine for hepatoma.
Chen CH; Huang LL; Huang CC; Lin CC; Lee Y; Lu FJ
Nutr Cancer; 2000; 38(2):287-95. PubMed ID: 11525608
[TBL] [Abstract][Full Text] [Related]
48. Zanthoxylum avicennae extracts induce cell apoptosis through protein phosphatase 2A activation in HA22T human hepatocellular carcinoma cells and block tumor growth in xenografted nude mice.
Dung TD; Chang HC; Chen CY; Peng WH; Tsai CH; Tsai FJ; Kuo WW; Chen LM; Huang CY
Int J Mol Med; 2011 Dec; 28(6):927-36. PubMed ID: 21874223
[TBL] [Abstract][Full Text] [Related]
49. Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis.
Shi YH; Ding ZB; Zhou J; Hui B; Shi GM; Ke AW; Wang XY; Dai Z; Peng YF; Gu CY; Qiu SJ; Fan J
Autophagy; 2011 Oct; 7(10):1159-72. PubMed ID: 21691147
[TBL] [Abstract][Full Text] [Related]
50. Crude extracts of Euchresta formosana radix induce cytotoxicity and apoptosis in human hepatocellular carcinoma cell line (Hep3B).
Hsu SC; Kuo CL; Lin JP; Lee JH; Lin CC; Su CC; Lin HJ; Chung JG
Anticancer Res; 2007; 27(4B):2415-25. PubMed ID: 17695533
[TBL] [Abstract][Full Text] [Related]
51. MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway.
Ying M; Tu C; Ying H; Hu Y; He Q; Yang B
J Pharmacol Exp Ther; 2008 Jun; 325(3):758-65. PubMed ID: 18323457
[TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
Cui W; Yu CH; Hu KQ
Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
[TBL] [Abstract][Full Text] [Related]
53. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
[TBL] [Abstract][Full Text] [Related]
54. Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma.
Huynh H; Soo KC; Chow PK; Tran E
Mol Cancer Ther; 2007 Jan; 6(1):138-46. PubMed ID: 17237274
[TBL] [Abstract][Full Text] [Related]
55. Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation.
Hsu WC; Ramesh S; Shibu MA; Chen MC; Wang TF; Day CH; Chen RJ; Padma VV; Li CC; Tseng YC; Huang CY
Phytomedicine; 2021 Feb; 82():153442. PubMed ID: 33412494
[TBL] [Abstract][Full Text] [Related]
56. Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal‑regulated kinase signaling pathway.
Zhang ZG; Qin CY
Mol Med Rep; 2014 Mar; 9(3):882-8. PubMed ID: 24366394
[TBL] [Abstract][Full Text] [Related]
57. Beneficial effect of flavonoid baicalein in cisplatin-induced cell death of human glioma cells.
Lee SW; Song GS; Kwon CH; Kim YK
Neurosci Lett; 2005 Jul 1-8; 382(1-2):71-5. PubMed ID: 15911124
[TBL] [Abstract][Full Text] [Related]
58. Baicalein protects cardiomyocytes against mitochondrial oxidant injury associated with JNK inhibition and mitochondrial Akt activation.
Huang HH; Shao ZH; Li CQ; Vanden Hoek TL; Li J
Am J Chin Med; 2014; 42(1):79-94. PubMed ID: 24467536
[TBL] [Abstract][Full Text] [Related]
59. Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells.
Choi EO; Park C; Hwang HJ; Hong SH; Kim GY; Cho EJ; Kim WJ; Choi YH
Int J Oncol; 2016 Sep; 49(3):1009-18. PubMed ID: 27571890
[TBL] [Abstract][Full Text] [Related]
60. Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo.
Yu W; Gu K; Yu Z; Yuan D; He M; Ma N; Lai S; Zhao J; Ren Z; Zhang X; Shao C; Jiang GL
Cancer Lett; 2013 Feb; 329(1):109-17. PubMed ID: 23142289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
